Janine Reiche

Dr. Janine Reiche


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 July 2018 in Reviews in Medical Virology
Verified
Journal Article
Closed access
PDF file
XMXiaolin Ma
Xiaolin Ma
TCTim OF Conrad
Tim OF Conrad
MAMaren Alchikh
Maren Alchikh
JRJanine Reiche
Janine Reiche
BSBrunhilde Schweiger
Brunhilde Schweiger
BRBarbara A Rath
Barbara A Rath

1 October 2010 in Melanoma Research
Verified
Journal Article
Closed access
JRJanine Reiche
Janine Reiche
GPGeorg Pauli
Georg Pauli
HEHeinz Ellerbrok
Heinz Ellerbrok
Human endogenous retroviruses (HERVs) are discussed as causative agents of various diseases including cancers. Expression of endogenous retroviral sequences can be induced by ultraviolet (UV) light, which is also considered as a cofactor in the development of cutaneous melanoma. Therefore, we investigated whether ultraviolet C (UVC) induces HERV-K rec and np9 expression in normal human epidermal melanocytes (NHEM) and in melanoma cell lines. NHEM and four different melanoma cell lines were irradiated with 10 and 30 mJ/cm(2) UVC, respectively. Expression of the HERV-K transcripts rec and np9 was measured 0, 6, 12, and 24 h after UV exposure by quantitative real-time PCR. In NHEM, HERV-K rec expression was significantly induced 24 h after UV exposure with 10 mJ/cm(2) UVC, whereas np9 expression transiently increased 6 and 12 h after irradiation with both UV doses. In contrast, in melanoma cell lines MEWO, G-361 and GR-M rec, and np9 expression was downregulated or remained unchanged after UV treatment. UVC irradiation induced HERV-K rec and np9 expression in NHEM, which might be an indicator of a functional role of Rec and/or Np9 in melanoma formation.

28 March 2024 in Eurosurveillance
Verified
Journal Article
Open access
WCWei Cai
Wei Cai
SKSophie Köndgen
Sophie Köndgen
KTKristin Tolksdorf
Kristin Tolksdorf
RDRalf Dürrwald
Ralf Dürrwald
ESEkkehard Schuler
Ekkehard Schuler
JRJanine Reiche
Janine Reiche
Background: Non-pharmaceutical interventions (NPIs) during the COVID-19 pandemic affected respiratory syncytial virus (RSV) circulation worldwide. Aim: To describe, for children aged < 5 years, the 2021 and 2022/23 RSV seasons in Germany. Methods: Through data and 16,754 specimens from outpatient sentinel surveillance, we investigated RSV seasonality, circulating lineages, and affected children’s age distributions in 2021 and 2022/23. Available information about disease severity from hospital surveillance was analysed for patients with RSV-specific diagnosis codes (n = 13,104). Differences between RSV seasons were assessed by chi-squared test and age distributions trends by Mann–Kendall test. Results: RSV seasonality was irregular in 2021 (weeks 35–50) and 2022/23 (weeks 41–3) compared to pre-COVID-19 2011/12–2019/20 seasons (median weeks 51–12). RSV positivity rates (RSV-PR) were higher in 2021 (40% (522/1,291); p < 0.001) and 2022/23 (30% (299/990); p = 0.005) than in prior seasons (26% (1,430/5,511)). Known globally circulating RSV-A (lineages GA2.3.5 and GA2.3.6b) and RSV-B (lineage GB5.0.5a) strains, respectively, dominated in 2021 and 2022/23. In 2021, RSV-PRs were similar in 1 – < 2, 2 – < 3, 3 – < 4, and 4 – < 5-year-olds. RSV hospitalisation incidence in 2021 (1,114/100,000, p < 0.001) and in 2022/23 (1,034/100,000, p < 0.001) was approximately double that of previous seasons’ average (2014/15–2019/20: 584/100,000). In 2022/23, proportions of RSV patients admitted to intensive care units rose (8.5% (206/2,413)) relative to pre-COVID-19 seasons (6.8% (551/8,114); p = 0.004), as did those needing ventilator support (6.1% (146/2,413) vs 3.8% (310/8,114); p < 0.001). Conclusions: High RSV-infection risk in 2–4-year-olds in 2021 and increased disease severity in 2022/23 possibly result from lower baseline population immunity, after NPIs diminished exposure to RSV.

10 September 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EOEvangeline Evangeline Obodai
Evangeline Evangeline Obodai
JOJohn Kofi Odoom
John Kofi Odoom
TATheophilus Adiku
Theophilus Adiku
BGBamenla Goka
Bamenla Goka
TWThorsten Wolff
Thorsten Wolff
JRJanine Reiche
Janine Reiche
Acute lower respiratory tract infection (ALRI) is a leading cause of childhood morbidity and mortality in developing countries. Globally, human respiratory syncytial virus (HRSV) is the most common pathogen of ALRI in infants and children. However, age-stratified HRSV disease burden data are largely absent from Africa, which is a key gap in informing an evidence-based recommendation for the introduction of an HRSV vaccine by the WHO. This study investigated the presence of HRSV in respiratory specimens from 552 children <5 years old with ALRI from Accra, Ghana in 2006 and 2013–2014 by real-time PCR. Of HRSV-positive samples the second hypervariable region of the viral G protein gene was sequenced and analyzed for phylogeny, characteristic amino acid substitutions, and potential glycosylation patterns. Further, HRSV infections have been characterized by age, symptoms and timely occurrence. HRSV was observed in 23% (127/552) of the children with ALRI, with the highest incidence in infants younger than one year (33%, 97/295, p = 0.013). Within the observed seasonal circulation time of HRSV from June (mid-wet season) to December (beginning of the dry season) the incidence of ALRI due to HRSV was as high as 46% (125/273). HRSV disease was significantly associated with (broncho-) pneumonia, bronchiolitis, LRTI, and difficulty in breathing. Phylogenetic characterization of HRSV strains from Ghana identified the circulation of the currently worldwide prevailing genotypes ON1 and BA9, and shows evidence of an independent molecular evolution of ON1 and BA9 strains in Ghana resulting in potentially new subgenotypes within ON1 and BA9, provisionally named ON1.5, ON1.6, and BA9-IV. This study addresses important knowledge gaps in the forefront of introducing the HRSV vaccine by providing information on the molecular evolution and incidence of HRSV in Accra (Ghana, Africa).

29 April 2022 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
WCWei Cai
Wei Cai
RDRalf Dürrwald
Ralf Dürrwald
BBBarbara Biere
Barbara Biere
BSBrunhilde Schweiger
Brunhilde Schweiger
WHWalter Haas
Walter Haas
JRJanine Reiche
Janine Reiche
Based on our national outpatient sentinel surveillance, we have developed a novel approach to determine respiratory syncytial virus (RSV) epidemic seasons in Germany by using RSV positivity rate and its lower limit of 95% confidence interval. This method was evaluated retrospectively on nine RSV seasons, and it is also well‐suited to describe off‐season circulation of RSV in near real time as observed for seasons 2020/21 and 2021/22 during the COVID‐19 pandemic. Prospective application is of crucial importance to enable timely actions for health service delivery and prevention.

14 July 2021 in Microorganisms
Verified
Journal Article
Open access
PDF file
DODjin-Ye Oh
Djin-Ye Oh
BBBarbara Biere
Barbara Biere
MGMarkus Grenz
Markus Grenz
TWThorsten Wolff
Thorsten Wolff
BSBrunhilde Schweiger
Brunhilde Schweiger
JRJanine Reiche
Janine Reiche
Human parainfluenza viruses (HPIVs) are important causes of respiratory illness, especially in young children. However, surveillance for HPIV is rarely performed continuously, and national-level epidemiologic and genetic data are scarce. Within the German sentinel system, to monitor acute respiratory infections (ARI), 4463 respiratory specimens collected from outpatients < 5 years of age between October 2015 and September 2019 were retrospectively screened for HPIV 1–4 using real-time PCR. HPIV was identified in 459 (10%) samples. HPIV-3 was the most common HPIV-type, with 234 detections, followed by HPIV-1 (113), HPIV-4 (61), and HPIV-2 (49). HPIV-3 was more frequently associated with age < 2 years, and HPIV-4 was more frequently associated with pneumonia compared to other HPIV types. HPIV circulation displayed distinct seasonal patterns, which appeared to vary by type. Phylogenetic characterization clustered HPIV-1 in Clades 2 and 3. Reclassification was performed for HPIV-2, provisionally assigning two distinct HPIV-2 groups and six clades, with German HPIV-2s clustering in Clade 2.4. HPIV-3 clustered in C1, C3, C5, and, interestingly, in A. HPIV-4 clustered in Clades 2.1 and 2.2. The results of this study may serve to inform future approaches to diagnose and prevent HPIV infections, which contribute substantially to ARI in young children in Germany.